ATE400566T1 - Benzofurane und benzothiophene - Google Patents
Benzofurane und benzothiopheneInfo
- Publication number
- ATE400566T1 ATE400566T1 AT04797711T AT04797711T ATE400566T1 AT E400566 T1 ATE400566 T1 AT E400566T1 AT 04797711 T AT04797711 T AT 04797711T AT 04797711 T AT04797711 T AT 04797711T AT E400566 T1 ATE400566 T1 AT E400566T1
- Authority
- AT
- Austria
- Prior art keywords
- benzofuranes
- benzothiophenes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0313615A FR2862646B1 (fr) | 2003-11-20 | 2003-11-20 | Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE400566T1 true ATE400566T1 (de) | 2008-07-15 |
Family
ID=34531152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04797711T ATE400566T1 (de) | 2003-11-20 | 2004-11-08 | Benzofurane und benzothiophene |
Country Status (16)
Country | Link |
---|---|
US (1) | US7371774B2 (de) |
EP (1) | EP1685122B1 (de) |
JP (1) | JP4819692B2 (de) |
KR (1) | KR20060101492A (de) |
CN (1) | CN1882562A (de) |
AR (1) | AR046645A1 (de) |
AT (1) | ATE400566T1 (de) |
AU (1) | AU2004295036B9 (de) |
BR (1) | BRPI0416790A (de) |
CA (1) | CA2546651C (de) |
DE (1) | DE602004014966D1 (de) |
ES (1) | ES2308270T3 (de) |
FR (1) | FR2862646B1 (de) |
MX (1) | MXPA06005591A (de) |
WO (1) | WO2005054226A1 (de) |
ZA (1) | ZA200605022B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2862645B1 (fr) * | 2003-11-20 | 2007-06-22 | Merck Sante Sas | Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
GB0506133D0 (en) * | 2005-03-24 | 2005-05-04 | Sterix Ltd | Compound |
CN101830872A (zh) * | 2010-04-14 | 2010-09-15 | 南方医科大学 | 一种3-羟基苯并呋喃类衍生物的合成方法 |
NZ743651A (en) | 2015-12-09 | 2023-07-28 | Univ Illinois | Benzothiophene-based selective estrogen receptor downregulators |
WO2018081168A2 (en) | 2016-10-24 | 2018-05-03 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective mixed estrogen receptor downregulators |
TWI823845B (zh) | 2017-01-06 | 2023-12-01 | 美商G1治療公司 | 用於治療癌症的組合療法 |
AU2018217809A1 (en) | 2017-02-10 | 2019-08-22 | G1 Therapeutics, Inc. | Benzothiophene estrogen receptor modulators |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1084290A (de) * | 1963-12-02 | 1900-01-01 | ||
SE351639B (de) * | 1964-11-11 | 1972-12-04 | Haessle Ab | |
JPH10175970A (ja) * | 1996-12-19 | 1998-06-30 | Mitsui Chem Inc | ベンゾチオフェン誘導体およびそれを有効成分として含有する医薬品 |
AU3791799A (en) * | 1998-05-12 | 1999-11-29 | American Home Products Corporation | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
WO2002024672A2 (en) * | 2000-09-19 | 2002-03-28 | Warner-Lambert Company Llc | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
CA2527934A1 (en) * | 2003-06-05 | 2004-12-16 | Warner-Lambert Company Llc | Tetrazol benzofurancarboxamides with p13k activity as therapeutic agents |
FR2862645B1 (fr) * | 2003-11-20 | 2007-06-22 | Merck Sante Sas | Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
-
2003
- 2003-11-20 FR FR0313615A patent/FR2862646B1/fr not_active Expired - Fee Related
-
2004
- 2004-11-08 AU AU2004295036A patent/AU2004295036B9/en not_active Ceased
- 2004-11-08 KR KR1020067009680A patent/KR20060101492A/ko not_active Withdrawn
- 2004-11-08 WO PCT/EP2004/012620 patent/WO2005054226A1/en active IP Right Grant
- 2004-11-08 MX MXPA06005591A patent/MXPA06005591A/es unknown
- 2004-11-08 DE DE602004014966T patent/DE602004014966D1/de not_active Expired - Lifetime
- 2004-11-08 AT AT04797711T patent/ATE400566T1/de not_active IP Right Cessation
- 2004-11-08 ES ES04797711T patent/ES2308270T3/es not_active Expired - Lifetime
- 2004-11-08 BR BRPI0416790-2A patent/BRPI0416790A/pt not_active Application Discontinuation
- 2004-11-08 CA CA2546651A patent/CA2546651C/en not_active Expired - Fee Related
- 2004-11-08 JP JP2006540238A patent/JP4819692B2/ja not_active Expired - Fee Related
- 2004-11-08 CN CNA2004800341918A patent/CN1882562A/zh active Pending
- 2004-11-08 EP EP04797711A patent/EP1685122B1/de not_active Expired - Lifetime
- 2004-11-08 US US10/579,996 patent/US7371774B2/en not_active Expired - Fee Related
- 2004-11-19 AR ARP040104274A patent/AR046645A1/es unknown
-
2006
- 2006-06-19 ZA ZA200605022A patent/ZA200605022B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2308270T3 (es) | 2008-12-01 |
ZA200605022B (en) | 2007-10-31 |
AU2004295036B2 (en) | 2010-12-23 |
CA2546651A1 (en) | 2005-06-16 |
KR20060101492A (ko) | 2006-09-25 |
EP1685122A1 (de) | 2006-08-02 |
BRPI0416790A (pt) | 2007-03-06 |
CA2546651C (en) | 2012-12-18 |
FR2862646B1 (fr) | 2006-02-24 |
US7371774B2 (en) | 2008-05-13 |
AR046645A1 (es) | 2005-12-14 |
AU2004295036A1 (en) | 2005-06-16 |
CN1882562A (zh) | 2006-12-20 |
EP1685122B1 (de) | 2008-07-09 |
AU2004295036B9 (en) | 2011-02-03 |
JP2007511556A (ja) | 2007-05-10 |
JP4819692B2 (ja) | 2011-11-24 |
FR2862646A1 (fr) | 2005-05-27 |
MXPA06005591A (es) | 2006-08-11 |
DE602004014966D1 (de) | 2008-08-21 |
WO2005054226A1 (en) | 2005-06-16 |
US20070066680A1 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1639007E (pt) | Bloqueadores de fcev e as suas utilizações tereapêuticas | |
DE602004006705D1 (de) | Knieschutzeinrichtung | |
DE60330847D1 (de) | Benzofuranderivat | |
DE102004061746A8 (de) | Alkinyl-substituierte Thiophene | |
DK1675852T3 (da) | Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner | |
DE602004003112D1 (de) | Steuerungsschaltung und rekonfigurierbarer logischer Block | |
IL200524A0 (en) | Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709 | |
DE602004003111D1 (de) | Tiefen-basiertes Antialiasing | |
IS8344A (is) | Útskipt þíófen og notkun þeirra | |
DE602004016683D1 (de) | Einrichtungssteuereinrichtung und einrichtungssteuerverfahren | |
DE60105195D1 (de) | Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitoren | |
EP1602655A4 (de) | Benzofuranderivat | |
ATE400566T1 (de) | Benzofurane und benzothiophene | |
NO20055308D0 (no) | Sjokkinnretning | |
DE502004011589D1 (de) | Silylierte carboxamide | |
DE502005008788D1 (de) | Mikrobizide silylierte carboxamide | |
UY3416Q (es) | Unidad aritmetica y de control | |
DE60336431D1 (de) | Aterial | |
NO20025475D0 (no) | Benzotiofenderivater | |
NO20020844L (no) | Oljelense | |
FR2853555B3 (fr) | Cadre de raquette | |
DE602004017496D1 (de) | Einrichtungssteuereinrichtung und einrichtungssteuerverfahren | |
DE602004018293D1 (de) | Fahrwerkanordnung | |
ATE420082T1 (de) | Benzothiophene als adenosinrezeptormodulatoren | |
DE602004016637D1 (de) | Abferkelstation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |